Aberrant SOCS3 Promoter Methylation as a Noninvasive Diagnostic Biomarker for Locally Advanced Prostate Cancer.
Demircan BernaTurgay TuranBurcu YucelSedef Altundag KaraSeda Salman YılmazAsif YildirimPublished in: Medeniyet medical journal (2020)
Our results indicated that SOCS3 could be a useful, noninvasive blood-based epigenetic biomarker for the diagnosis of locally advanced PCa.